-
2022-501489-24-00
First-line treatment of adult subjects with high-risk l 2025-03-28
-
2024-513550-30-00
Newly diagnosed Glioblastoma 2025-03-28
-
2024-516248-24-00
Hereditary Angioedema 2025-03-28
-
2024-512024-10-01
Adult patients with severe aortic stenosis scheduled fo 2025-03-28
-
2024-515214-41-00
advanced pancreatic cancer 2025-03-27
-
2023-504086-23-00
Subjects with PBC with a non-optimal response to UDCA. 2025-03-27
-
2024-514065-19-00
Acute asthma. Patients with moderate asthma attacks wil 2025-03-27
-
2024-513862-20-00
Chronic Rhinosinusitis with Nasal Polyposis 2025-03-26
-
2024-516219-25-00
psoriatic arthritis 2025-03-25
-
2023-507972-35-01
Allergic contact dermatitis 2025-03-24
-
2024-515445-42-00
Node-positive, Estrogen Receptor-positive, HER2-negativ 2025-03-24
-
2023-505311-20-01
Metastatic Non-Small Cell Lung Cancer 2025-03-21
-
2024-515256-21-00
Fecal incontinence 2025-03-21
-
2024-514277-21-00
Actinic keratosis 2025-03-19
-
2024-514285-39-00
risk for postoperative complications after general surg 2025-03-19
-
2024-515566-13-00
Diffuse Large B-Cell Lymphoma (DLBCL) 2025-03-19
-
2023-508307-21-00
Prader-Willi syndrome 2025-03-19
-
2023-509070-36-00
Major Depressive Disorder with Insomnia Symptoms 2025-03-18
-
2024-514648-10-00
Idiopathic Inflammatory Myopathy (including dermatomyos 2025-03-14
-
2024-514594-21-00
Heterozygous Familial Hypercholesterolemia 2025-03-13
-
2023-508845-41-00
Active juvenile idiopathic arthritis subtypes enthesiti 2025-03-11
-
2024-513547-82-00
Transthyretin Amyloidosis 2025-03-11
-
2023-503836-41-00
Major Depressive Disorder 2025-03-10
-
2023-509907-34-01
acute ischemic stroke 2025-03-10